➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Colorcon
Baxter
McKesson
Harvard Business School

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 4,308,026

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,308,026
Title: Agglutination inhibition immunoassay for hapten using two differently sensitized particles
Abstract:An immunochemical process and the reagents for measuring hapten by using an agglutination inhibition reaction, anti-hapten antibody sensitized particles and a hapten-carrier conjugate which is capable of agglutinating said particles.
Inventor(s): Mochida; Ei (Tokyo, JP), Ogawa; Nobuhisa (Omiya, JP), Shinkai; Hiroyuki (Kawagoe, JP), Kudo; Takashi (Tokyo, JP)
Assignee: Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP)
Application Number:06/059,338
Patent Claims:see list of patent claims

Details for Patent 4,308,026

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bpl ALBUMINEX albumin human SOLUTION 125644 1 2020-05-27   Start Trial Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP) 1998-12-29 search
Kedrion S.p.a KEDBUMIN albumin (human) INJECTION, SOLUTION 125384 1 2011-09-15   Start Trial Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP) 1998-12-29 search
Octapharma Usa Inc ALBUMIN (HUMAN) albumin human SOLUTION 125154 1 2006-10-17   Start Trial Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP) 1998-12-29 search
Csl Behring Llc ALBUMINAR-25 albumin (human) SOLUTION 103955 1 2009-01-06   Start Trial Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP) 1998-12-29 search
Grifols Usa, Llc HUMAN ALBUMIN GRIFOLS albumin (human) SOLUTION 103352 1 2003-06-11   Start Trial Mochida Seiyaku Kabushiki Kaisha (Tokyo, JP) 1998-12-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Harvard Business School
Colorcon
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.